1ST AMENDMENT to SUPPLY AND SERVICES AGREEMENT BETWEEN VICAL INCORPORATED AND ASTELLAS PHARMA INC.Supply and Services Agreement • August 8th, 2012 • Vical Inc • Biological products, (no disgnostic substances)
THIS AMENDMENT is made and entered into as of August 6, 2012 (“Amendment Effective Date”) by and between VICAL INCORPORATED, a Delaware corporation (“Vical”), having an address of 10390 Pacific Center Court, San Diego, California, 92121, USA, and ASTELLAS PHARMA INC., a company organized under the laws of Japan (“Astellas”), having an address of 3-11, Nihonbashi-Honcho 2-chome, Chuo-Ku, Tokyo 103-8411, Japan.
CONSULTING AGREEMENT FOURTH AMENDMENTConsulting Agreement • August 8th, 2012 • Vical Inc • Biological products, (no disgnostic substances)
This Fourth Amendment, to the Consulting Agreement (the “Fourth Amendment”), is made effective as of June 30, 2012 (the “Fourth Amendment Effective Date”) and is entered into by and between Vical Incorporated (“Vical”), a Delaware Corporation, having a place of business at 10390 Pacific Center Court, San Diego, CA 92121-4340 and Gary A. Lyons (the “Consultant”), an individual having a principal address of 1344 Stratford Court, Del Mar, CA 92014.
1ST AMENDMENT to Ex-U.S. LICENSE AGREEMENT BETWEEN VICAL INCORPORATED AND ASTELLAS PHARMA INC.ex-u.s. License Agreement • August 8th, 2012 • Vical Inc • Biological products, (no disgnostic substances)
THIS AMENDMENT is made and entered into as of August 6, 2012 (“Amendment Effective Date”) by and between VICAL INCORPORATED, a Delaware corporation (“Vical”), having an address of 10390 Pacific Center Court, San Diego, California, 92121, USA, and ASTELLAS PHARMA INC., a company organized under the laws of Japan (“Astellas”), having an address of 3-11, Nihonbashi-Honcho 2-chome, Chuo-Ku, Tokyo 103-8411, Japan.
1ST AMENDMENT to U.S. LICENSE AGREEMENT BETWEEN VICAL INCORPORATED AND ASTELLAS PHARMA INC.u.s. License Agreement • August 8th, 2012 • Vical Inc • Biological products, (no disgnostic substances)
THIS AMENDMENT is made and entered into as of August 6, 2012 (“Amendment Effective Date”) by and between VICAL INCORPORATED, a Delaware corporation (“Vical”), having an address of 10390 Pacific Center Court, San Diego, California, 92121, USA, and ASTELLAS PHARMA INC., a company organized under the laws of Japan (“Astellas”), having an address of 3-11, Nihonbashi-Honcho 2-chome, Chuo-Ku, Tokyo 103-8411, Japan.
